Clinical Trial Update: Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ramelteon as an adjunct therapy in non-diabetic patients with schizophrenia and related disorders; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-09-13